Bacterial and fungal keratitis in Upper Egypt: In vitro screening of enzymes, toxins and antifungal activity

Indian Journal of Ophthalmology

Volumn 62, Issue 2, 2014, Pages 196-203

  Gharamah, Abdullah ^a   Moharram, Ahmed ^b   Ismail, Mady ^b   Al Hussaini, Ashraf ^c  

^a SCHOOL OF PHYSICS   (Malaysia)

^b Faculty of Sciences   (India)

^c Assiut University Faculty of Medicine   (Egypt)

Author keywords

Bacterial; extracellular enzymes; fungal; keratitis; toxins

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BACTERIAL TOXIN; MYCOTOXIN;

BACTERIUM; CORNEA; DRUG EFFECTS; EGYPT; EYE INFECTIONS, BACTERIAL; EYE INFECTIONS, FUNGAL; FUNGUS; HUMAN; INCIDENCE; ISOLATION AND PURIFICATION; KERATITIS; METABOLISM; MICROBIOLOGY; SECRETION (PROCESS);

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTERIA; BACTERIAL TOXINS; CORNEA; EGYPT; EYE INFECTIONS, BACTERIAL; EYE INFECTIONS, FUNGAL; FUNGI; HUMANS; INCIDENCE; KERATITIS; MYCOTOXINS;

EID: 84898737494     PISSN: 03014738     EISSN: 19983689     Source Type: Journal    
DOI: 10.4103/0301-4738.116463     Document Type: Article

References (30)

1. Ahn M, Yoon K, Ryu S, Cho N, You I. Clinical Aspects and Prognosis of Mixed Microbial (Bacterial and Fungal) Keratitis. Cornea 2011;30:409-13.
2. WHO, World Health Organization. Causes of blindness and visual impairment. Available from: http://www. who.int/blindness/causes/en/index.html. (Last accessed on 2011 Nov 11).
3. Feilmeier MR, Sivaraman KR, Oliva M, Tabin GC, Gurung R. Etiologic Diagnosis of Corneal Ulceration at a Tertiary Eye Center in Kathmandu, Nepal. Cornea 2010;29:1380-5.
4. Thomas PA. Current Perspectives on Ophthalmic Mycoses. Clin Microbiol Rev 2003;16:730-97.
5. Liesegang TJ. Bacterial keratitis. In: Kaufman HE, Barron BA, McDonald, editors. The Cornea. 1st ed. Bosten: ButterworthHeinemann; 1998. p. 159-211.
6. Thomas PA. Mycotic keratitis: An underestimated mycosis. J Med Vet Mycol 1994;32:235-54.
7. Dorner JW. Chromatographic analysis of mycotoxins. In: Shibamoto T, editor. Chromatographic analysis of environmental and food toxicants. 1st ed. New York: Marcel Dekker Inc.; 1998. p. 113-30.
8. Marangon FB, Miller D, Giaconi JA, Alfonso EC. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am J Ophthalmol 2004;137:820-5.
9. Manzouri B, Vafidis GC, Wyse RK. Pharmacotherapy of fungal eye infections. Expert Opin Pharmacol 2001;2:1849-57.
10. De Hoog GS, Guarro J, Gene J, Figueras MJ. Atals of Clinical Fungi. 2nd ed. Netherland: Centraalburearu voor Schimmelcultures; 2000.
11. Ryan KJ, Ray CG, Sherris JC. Sherris Medical Microbiology. 4th ed. USA: McGrawHill Companies Inc.; 2004.
12. Paterson RR, Bridge PD. Biochemical techniques for filamentous fungi. Surrey: Int. Mycol. Instit. CAB International; 1994.
13. Collins GH, Lyne PM, Grange JM. Microbiological methods. 7th ed. Cambridge: ButterworthHeinemann; 1995.
14. Ismail MA. Deterioration and spoilage of peanuts and desiccated coconuts from two subSaharan tropical East African countries due to the associated mycobiota and their degradative enzymes. Mycopathologia 2001;150:67-84.
15. Gonzalez Pereyra ML, Rosa CA, Dalcero AM, Cavaglieri LR. Mycobiota and mycotoxins in malted barley and brewer's spent grain from Argentinean breweries. Lett Appl Microbiol 2011;53:649-55.
16. AOAC. Official Methods of Analysis. 1st ed. Arlington: AOAC International; 1995.
17. Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, et al. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: Six years of global surveillance. J Clin Microbiol 2008;46:150-6.
18. Giese MJ, Berliner JA, Riesner A, Wagar EA, Mondino BJ. A comparison of the early inflammatory effects of an agar/sar-versus a wild type strain of Staphylococcus aureus in a rat model of endophthalmitis. Curr Eye Res 1999;18:177-85.
19. Henderson B, Wilson M. Cytokine induction by bacteria: Beyond lipopolysaccharide. Cytokine 1996;8:269-82.
20. Hobden JA. Pseudomonas aeruginosa proteases and corneal virulence. DNA Cell Biol 2002;21:391-6.
21. Cejkova J, Vejrazka M, Platenik J, Stipek S. Agerelated changes in superoxide dismutase, glutathione peroxidase, catalase and xanthine oxidoreductase/xanthine oxidase activities in the rabbit cornea. Exp Gerontol 2004;39:1537-43.
22. Gopinathan U, Ramakrishna T, Willcox M, Rao CM, Balasubramanian D, Kulkarni A, et al. Enzymatic, clinical and histologic evaluation of corneal tissues in experimental fungal keratitis in rabbits. Exp Eye Res 2001;72:433-42.
23. Zhu WS, Wojdyla K, Donlon K, Thomas PA, Eberle HI. Extracellular proteases of Aspergillus flavus. Diagn. Clin Microbiol Infect 1990;13:491-7.
24. Raza SK, Mallett AI, Howell SA, Thomas PA. An in vitro study of the sterol content and toxin production of Fusarium isolates from mycotic keratitis. J Med Microbiol 1994;41:204-8.
25. Tanure MA, Cohen EJ, Grewal S, Rapuano CJ, Laibson PR. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea 2000;19:307-12.
26. Kaushik S, Ram J, Brar GS, Jain AK, Chakraborti A, Gupta A. Intracameral amphotericin B: Initial experience in severe keratomycosis. Cornea 2001;20:715-9.
27. Richardson MD, Warnock DW. Antifungal drugs. In: Fungal infection, diagnosis and management. 3rd ed. Oxford: Black Publishing Ltd.; 2003. p. 30-61.
28. Mahmoud YA. Efficacy of cetrimide as a promising antifungal agent against Fusarium solani human corneal ulcer. Assiut Univ J Bot 2005;34:463-75.
29. ALHussaini MK, AbdelKader MI, AbuGhadeer AA, ALHussaini AK. Keratomycosis diagnosis and therapy with ketoconazole. Bull Ophthalmol Soc Egypt 1988;81:113-7.
30. Chhablani J. Fungal endophthalmitis. Expert Rev Anti Infect Ther 2011;9:1191-201.